[Mediators of inflammation's clinical relevance in multiple myeloma].
Multiple myeloma is a blood disease characterized amongst other things by at least 10% plasmocytes in the bone marrow. The illness is always lethal. The Salmon & Durie classification is well established to evaluate the prognosis. Other parameters are under study in order to supplement it, among them mediators of inflammation such as CRP and LDH. A 5-year study assessing these 2 parameters and their clinical relevance is presented.